Aldeyra Therapeutics, Inc. (ALDX) Class Action Lawsuit (July 2023)
Closed1:23cv11737 • July 31, 2023
Class Period Start
January 7, 2021
Class Period End
October 16, 2023
PSLRA Deadline
September 29, 2023
Case Allegations
10b5
Statutes of Repose
Jan 7, 2024
Country
United States
Court
Federal Court
Docket History
Apr 18, 2025
Mar 14, 2025
Motion to Dismiss Granted (opens in a new tab)
The court has granted the defendants' request to dismiss the lawsuit. Depending on the court's decision, the plaintiffs may be allowed to file an updated complaint or pursue an appeal.
Mar 4, 2024
Motion to Dismiss (opens in a new tab)
After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.
Jan 2, 2024
First Amended Complaint (opens in a new tab)
A new complaint has been filed on behalf of certain investors in Aldeyra Therapeutics, Inc.. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.
Nov 1, 2023
Appointment of Lead Plaintiff (opens in a new tab)
The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.
Jul 31, 2023
First Filed Complaint (opens in a new tab)
A securities fraud class action complaint has been filed on behalf of certain investors in Aldeyra Therapeutics, Inc..